VerifyRecall
Alerts
RECALL RECORD — CLASS IIRecall closedF-0628-2019/FDA enforcement
Pepsico Gatorade Plant·Food·Oct 1, 2018

Gatorade Vanilla Protein Shake, 330-ml, Primary Package Hdpe in a 12pk Case

What you need to know

Class II

  • What happened

    Gatorade is voluntarily recalling a limited number of 12-pack 330-mL Gatorade Vanilla Protein Shake bottles because they may contain Bacillus cereus bacteria.

  • Health risk

    The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. A safety issue that does not fit the standard pathogen, allergen, chemical or quality categories.

  • Action required

    Check the identifying codes below and stop using the product. Return it to the retailer for a refund or dispose of it safely, following the recall notice.

Recall closed · classified by the FDAMI, ILMore food

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Share via WhatsApp

Match before you discard

Product identification

Source: FDA FOOD

Brand namePepsico Gatorade Plant
Recalling firmPepsico Gatorade PlantIndianapolis, IN, United States
UPC / barcodesNo UPC listed in the FDA enforcement record.
Lot / date codes
  • Gatorade Vanilla Protein Shake, 330-mL, Primary Package HDPE in a 12pk case, One manufacture date: DT040988, use by date: JAN 04 19
Distribution area
MIIL

Domestic only: MI, IL

United States

Quantity affectedTen 12-pack cases (120 individual 330mL bottles)
Recall initiationFDA report date: November 28, 2018
FDA recall numberF-0628-2019

Beyond the headline

The recall, in context

Pepsico Gatorade Plant initiated this food recall on October 1, 2018. The FDA enforcement report states: Gatorade is voluntarily recalling a limited number of 12-pack 330-mL Gatorade Vanilla Protein Shake bottles because they may contain Bacillus cereus bacteria. The FDA report lists distribution as: Domestic only: MI, IL.

The FDA enforcement report describes the reason as: Gatorade is voluntarily recalling a limited number of 12-pack 330-mL Gatorade Vanilla Protein Shake bottles because they may contain Bacillus cereus bacteria.

Gatorade Vanilla Protein Shake, 330-ml, Primary Package Hdpe in a 12pk Case was made or distributed by Pepsico Gatorade Plant in Indianapolis, IN, United States. This page reflects FDA report F-0628-2019, dated November 28, 2018.

Why this is a Class II recall

Class II means the product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. In this recall, a safety issue that does not fit the standard pathogen, allergen, chemical or quality categories.

FDA definition

The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the lot and date codes against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Product safety recall

Symptoms to watch for

The official enforcement report describes the specific risk. Follow the recall notice, check the product codes and do not use a product that may be affected.

Higher-risk groups

Children, pregnant people, older adults and people with weakened immune systems should take extra care when a product's safety is uncertain.

What to do now

  1. 1Stop using or eating the product and keep it away from children and pets.
  2. 2Check the UPC and lot/date codes on this page and follow the official recall notice for disposal or return.
  3. 3Seek medical advice if anyone develops severe or worrying symptoms after exposure.

Read the official source record for the specific hazard and instructions.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Gatorade Vanilla Protein Shake, 330-ml, Primary Package Hdpe in a 12pk Case recall?

Pepsico Gatorade Plant recalled Gatorade Vanilla Protein Shake, 330-ml, Primary Package Hdpe in a 12pk Case in an FDA Class II enforcement action reported as F-0628-2019. Gatorade is voluntarily recalling a limited number of 12-pack 330-mL Gatorade Vanilla Protein Shake bottles because they may contain Bacillus cereus bacteria.

What should I do if I bought this product?

Check the identifying codes below and stop using the product. Return it to the retailer for a refund or dispose of it safely, following the recall notice. Stop using or eating the product and keep it away from children and pets. Check the UPC and lot/date codes on this page and follow the official recall notice for disposal or return. Seek medical advice if anyone develops severe or worrying symptoms after exposure.

Is the Pepsico Gatorade Plant recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-0628-2019. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Related alerts

Recent Other safety concern recalls

All alerts
Class II·

Sempio Food Services, INC

Sempio Yellow Peach

Elevated level of lead in canned peaches

INFood
Class II·

Stewart's Shops Corp.

Stewarts Shops Vanilla Heavenly Medley 1/2 Gallon (1.89 L)

Foreign object: May contain pieces of metal

NY, VT, NHFood

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.